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Since STAT3 activation is involved in tumor progression and
metastasis, we investigated the effect of GSNO in cell culture and
mouse xenograft model of head and neck squamous cell carci-
noma (HNSCC). GSNO treatment of HNSCCN cell lines reversibly
decreases the activation (phosphorylation) of STAT3 in a concen-
tration dependent manner. The reduced STAT3/NF-kB activity by
GSNO correlated with decreased cell proliferation and increased
apoptosis of HNSCC cells. In HNSCC mouse xenograft model, the
tumor growth was reduced by systemic treatment with GSNO and
was further reduced when the treatment combined with radiation
and cisplatin. Accordingly, GSNO treatment also resulted in
decreased levels of pSTAT3 and tumor growth regulators (ie. cyclin
D2, VEGF and Bcl-2) in tumor tissue. In summary, these ﬁndings
have implications for the development of new therapeutics
targeting of STAT3 for treating diseases associated with inﬂam-
matory/immune responses and abnormal cell proliferation, includ-
ing cancer.
http://dx.doi.org/10.1016/j.redox.2015.09.021
Mechanisms Of Hypoxia-Induced Immune Escape In
Cancer And Their Regulation By Nitric Oxide
Charles Graham, Ivraym Barsoum, Judy Kim, Madison Black, Robert
D. Siemens
Queen’s University, Kingston, Canada
The acquired ability of tumour cells to avoid destruction by
immune effector mechanisms (immune escape) is important for
malignant progression. Also associated with malignant progression is
tumour hypoxia, which induces aggressive phenotypes such as inva-
sion, metastasis and drug resistance in cancer cells. Our studies
revealed that hypoxia contributes to escape from innate immunity
by increasing tumour cell expression of the metalloproteinase
ADAM10 in a manner dependent on accumulation of the alpha
subunit of the transcription factor hypoxia-inducible factor-1 (HIF-
1α). Increased ADAM10 expression leads to shedding of the NK
cell-activating ligand, MICA, from the surface of tumour cells, thereby
resulting in resistance to NK cell-mediated lysis. Our more recent
studies demonstrated that hypoxia, also via HIF-1α accumulation,
increases the expression of the inhibitory co-stimulatory ligand PD-
L1 on tumour cells. Elevated PD-L1 expression leads to escape from
adaptive immunity via increased apoptosis of CD8+ cytotoxic T
lymphocytes. Accumulating evidence indicates that hypoxia-induced
acquisition of malignant phenotypes, including immune escape, is in
part due to impaired nitric oxide (NO)-mediated activation of cGMP
signalling and that restoration of cGMP signalling prevents such
hypoxic responses. We have shown that NO/cGMP signalling inhibits
hypoxia-induced malignant phenotypes likely in part by interfering
with HIF-1α accumulation via a mechanism involving calpain. These
ﬁndings indicate that activation of NO/cGMP signalling may have
useful applications in cancer therapy.
http://dx.doi.org/10.1016/j.redox.2015.09.022
Evaluating The Role Of Nitric Oxide Synthase In
Oncogenic Ras-Driven Tumorigenesis
Chris Counter
Duke University Medical Center, Durham, USA
We previously reported that oncogenic KRAS activation of the
PI3K/AKT pathway stimulates the remaining wild-type HRAS and
NRAS proteins in a manner dependent upon both eNOS expression
and C118 in HRAS and NRAS, which promoted tumor growth.
Interestingly however, we recently found that loss of wild-type HRAS,
NRAS, and even more potently, loss of both of these genes actually
enhanced oncogenic KRAS-driven early tumorigenesis. Taken together,
these results indicate that wild-type RAS proteins are tumor suppres-
sing early in tumorigenesis, but tumor promoting in more malignant
settings. Knock-in of a C118S mutation into an endogenous wild-type
RAS gene did not, however, hamper oncogenic KRAS-driven tumor
initiation. As such, redox-dependent reactions with C118 of wild-type
RAS proteins are unlikely to be responsible for the tumor suppressive
role of wild-type RAS proteins. This suggests that the redox-dependent
reactions with C118 of wild-type RAS proteins are more important in
more malignant settings. Given this, it stands to reason that inhibiting
redox-dependent reactions like S-nitrosylation of wild-type RAS
proteins may be more effective in established cancer settings. Indeed,
we ﬁnd that in three different models of KRAS-driven cancers-skin,
pancreatic and lung- the general NOS inhibitor L-NAME reduced tumor
burden and/or extended the lifespan of mice. Since oncogenic RAS has
so far proven refractory to pharmacologic inhibition, targeting NOS
activity may be an actionable approach to inhibiting RAS signaling for
the treatment of a broad spectrum of cancers.
http://dx.doi.org/10.1016/j.redox.2015.09.023
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Nitric Oxide And Hypoxia Response In Pluripotent
Stem Cells
Estefanía Caballano Infantes, Ana Belén Hitos Prados, Irene
Díaz Contreras, Gladys M. Cahuana, Abdelkrim Hmadcha, Franz
Martín Bermudo, Bernat Soria, Juan R. Tejedo Huamán, Francisco J.
Bedoya Bergua
Andalusian Molecular Biology and Regenerative Medicine Centre
(CABIMER), Sevilla, Spain
The expansion of pluripotent cells (ESCs and iPSCs) under condi-
tions that maintain their pluripotency is necessary to implement a cell
therapy program. Previously, we have described that low nitric oxide
(NO) donor diethylenetriamine/nitric oxide adduct (DETA-NO) added
to the culture medium, promote the expansion of these cell types. The
molecular mechanisms are not yet known. We present evidences that
ESC and iPSCs in normoxia in presence of low NO triggers a similar
response to hypoxia, thus maintaining the pluripotency. We have
studied the stability of HIF-1α (Hypoxia Inducible Factor) in presence
of low NO. Because of the close relationship between hypoxia,
metabolism, mitochondrial function and pluripotency we have ana-
lyzed by q RT-PCR the expression of genes involved in the glucose
metabolism such as: HK2, LDHA and PDK1; besides other HIF-1α
target gene. We further analyzed the expression of genes involved in
mitochondrial biogenesis such as PGC1α, TFAM and NRF1 andwe have
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observed that low NO maintains the same pattern of expression that
in hypoxia. The study of the mitochondrial membrane potential using
Mito-Tracker dye showed that NO decrease the mitochondrial func-
tion. We will analyze other metabolic parameters, to determinate if
low NO regulates mitochondrial function and mimics Hypoxia
Response. The knowledge of the role of NO in the Hypoxia Response
and the mechanism that helps to maintain self-renewal in pluripotent
cells in normoxia, can help to the design of culture media where NO
could be optimal for stem cell expansion in the performance of future
cell therapies.
http://dx.doi.org/10.1016/j.redox.2015.09.024
Redox Regulation Of Metabolic And Signaling Path-
ways By Thioredoxin And Glutaredoxin In Nitric
Oxide Treated Hepatoblastoma Cells
C. Alicia Padilla Peña, Raúl González, María J. López-Grueso,
J. Antonio Bárcena
Department of Biochemistry and Molecular Biology, IMIBIC, Univer-
sity of Córdoba, Córdoba, Spain
Background: NO has an antiproliferative action on HepG2 cells and
Thioredoxin (Trx) and Glutaredoxin (Grx) have denitrosilase and
deglutathionylase activities.
Aims: To ascertain whether Trx and/or Grx systems intermediate
the anti-proliferative effect of NO on hepatoblastoma cells by
modulating the redox-state of key proteins.
Methods: HepG2 cells overexpressing Nitric Oxide Synthase-3
(NOS-3) were transfected with speciﬁc siRNA to silence Trx1 and
Grx1. The expression and thiolic redox state of proteins were
determined by Western blot and redox mobility shift assay.
Results: Overexpression of NOS3 increased the levels and activities
of proteins of the redoxin systems, Trx1, Grx1, TrxR1 and TxnIP,
and the levels of signaling proteins (Akt1, pAkt1-Ser473, MapK,
pMapK, Stat3, Fas). The thiolic redox state of Trx1, Grx1 and Akt1
shifted to more oxidized. Increases were also observed in Pro-
apoptotic Caspase-3 fragment levels; caspase 3, 8 and 9 activities;
antiapoptotic (Bcl-2); mitochondrial energetic (Aco2) and heme
(Urod) metabolism; Glycolysis (Pkm2); and pentose phosphate
pathway (Tkt). However, two cytosolic proteins related to iron
(Aco1) and one carbon (Mat2) metabolism decreased markedly.
Moreover, the redox state of Urod and Aco1 shifted to more
oxidized cysteines.
Trx1 or Grx1 silencing augmented Tyr nitration and diminished
cell proliferation in WT cells, but attenuated the antiproliferative effect
on NO, the increase of Fas, Akt1 and pAkt1-Ser473 and the oxidative
modiﬁcation of Akt1 in NOS3 cells.
Conclusions: Trx1 and Grx1 exert contradictory inﬂuences on
HepG2 cells. They are required for proliferation but they also
contribute to antiproliferative effect of NO, associated to Akt1
redox changes.
http://dx.doi.org/10.1016/j.redox.2015.09.025
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Cellular Protective Mechanisms Of Inducible Nitric
Oxide Synthase
Timothy R. Billiar
Department of Surgery, University of Pittsburgh, USA
The inducible nitric oxide synthase (iNOS) is expressed constitu-
tively but also induced in a number of epithelial cell types. iNOS
regulates a number of cellular processes in these cell types without
exerting toxicity. Among these functions is protection from cellular
injury mediated by pro-apoptotic signals. We have had long-standing
interest in the cell protective roles of iNOS in hepatocytes. We
demonstrated that the upregulation of iNOS protects hepatocytes
and the liver from TNF-mediated toxicity. This includes the inhibition
of caspase activity through s-nitrosation. However, some of the effects
are mediated through cGMP. Exploration into the mechanisms of the
cGMP-mediated protection identiﬁed a role for the iNOS/NO/cGMP
pathway in the activation of ADAM17 (TACE), which is a sheddase that
cleaves a number of cell surface receptors including TNF receptor type
1 (TNFR1). The activation is associated with the phosphorylation of
TACE.
The iNOS/NO/cGMP/TACE pathway can be augmented by PDE5
inhibitors and reduce organ injury in the setting of sepsis. The
implications go beyond acute pathophysiology and may be
important to the mechanisms of iNOS in promoting aggressive
cancers.
http://dx.doi.org/10.1016/j.redox.2015.09.026
Post-Translational Nitric Oxide–Dependent Modiﬁca-
tions In Immune System
Antonio Martínez-Ruiz
Hospital Universitario de la Princesa, Instituto de Investigación
Sanitaria Princesa (IP) Madrid, Spain
Nitric oxide non classical signalling is exerted through a series
of covalent protein post-translational modiﬁcations, which include
modiﬁcation of cysteine residues by S-nitrosylation and S-glu-
tathionylation.
A key process in adaptive immunity is the immune synapse
that tightly couples T cells with antigen presenting cells, triggering
antigen recognition by T cells. In this highly regulated process, we
have shown that eNOS is activated, inducing protein S-nitrosyla-
tion. While both N-Ras and K-Ras are present in T cells, only N-Ras,
which colocalizes in the Golgi with eNOS, is S-nitrosylated and
activated during the immune synapse, providing an example of
short-range selectivity of NO signalling through S-nitrosylation.
We have developed proteomic methods to detect S-nitrosyla-
tion and reversible cysteine oxidations. We have applied them to
detecting S-nitrosylated proteins in macrophage activation, high-
lighting the role of denitrosylase mechanism, particularly the
thioredoxin pathway, in protecting macrophages from self-mod-
iﬁcation.
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